HD-OPM Archive
Topics › Cancer

High-dose IV vitamin C plus chemotherapy doubled survival in a small pancreatic trial

Louis Nervegna · Jan 30, 2026 · ♥ 12 reactions · 4 comments · original Facebook post
CancerSupplements & vitamins
↻ This is a repost. The main version (highest ranked) is IV vitamin C plus chemotherapy doubled survival to 16 months in pancreatic cancer trial · Dec 04, 2024.
AI summary & key facts

Louis shares University of Iowa news of a small phase 2 trial in which high-dose IV vitamin C added to chemotherapy doubled survival in metastatic pancreatic cancer. He notes it is unrelated to heart disease.

(no text — see the shared post below)

Research cited

High dose intravenous vitamin C plus standard of care chemotherapy doubles survival in metastatic pancreatic cancer, as compared to chemotherapy alone.

This was a small phase 2 trial, which was recently published.

This is unrelated to heart disease. But given the interest in vitamin C in the group, I thought people would find it interesting.

Intravenous vitamin C has a long controversial history in oncology, dating all the way back to initial studies by Linus Pauling and Ewan Cameron in the 1970’s. It failed in the early 2000’s in trials at the NIH as a monotherapy. But this new trial suggests that it might be very promising in pancreatic adenocarcinoma when combined with the right chemotherapy.

Quoted:

“This is a deadly disease with very poor outcomes for patients. The median survival is eight months with treatment, probably less without treatment, and the five-year survival is tiny,” says Joe Cullen, MD, University of Iowa professor of surgery, and radiation oncology, and senior author of the study. “When we started the trial, we thought it would be a success if we got to 12 months survival, but we doubled overall survival to 16 months. The results were so strong in showing the benefit of this therapy for patient survival that we were able to stop the trial early.”

#vitamincHD #pancreaticcancerHD #cancerHD

← newer: JACC issues Expression of Concern on KETO-CTA 'Plaque Begetsolder: IV vitamin C doubled survival from 8 to 16 months in 34 panc →